Market Research Reports- Consulting Analysis Crystal Market Research Breast Imaging Technologies Market | Page 2

stringent regulatory approval procedures and superior cost of breast imaging systems are expected to
restrain the market growth during the forecast period.
Ionizing breast imaging technologies segment dominated the overall market in 2016 to their capability to
detect breast cancer at an early stage thereby escalating the odds of survival of the patients. Full-field
digital mammography segment dominated the ionizing breast imaging technologies market in 2016 as the
technology uses less radiation as compared to film mammography. Non-ionizing breast imaging
technologies segment is projected to witness fastest growth during the forecast period owing to the
introduction of advanced imaging modalities such as automated whole breast ultrasound technology.
Breast MRI segment held the largest share of the non-ionizing breast imaging technologies market in
2016 owing to its high sensitivity towards small abnormalities and its ability to visualize the breast in any
orientation.
U.S. held the major share of the North American breast imaging technologies market in 2016 owing to
high prevalence of breast cancer along with the presence of highly advanced healthcare infrastructure in
the country. Emerging markets such as China and India will experience significant growth during the
forecast period due to increasing awareness related to early detection of breast cancer and rising
healthcare expenditure in these countries.
Request a sample copy of Breast Imaging Technologies Market Research Report @
https://www.crystalmarketresearch.com/report-sample/HC06156
The major players operating in the global breast imaging technologies market emphasize on product
development and innovation along with strategic collaborations such as partnerships, acquisitions, and
agreements in order to retain and improve their competitive position in the market. For instance, in June
2017, Hologic, Inc., obtained FDA approval for its Genius 3D Mammography exam as the only FDA
approved mammogram superior to standard 2D mammography in terms of routine screening of breast
cancer in women with dense breasts. Some of the key players in the global breast imaging technologies
market are, GE Healthcare (a division of General Electric Company), Dilon Technologies, Hologic, Inc.,
Gamma Medica Inc., Koninklijke Philips N.V., Siemens AG, Toshiba Medical Systems Corporation
(acquired by Canon, Inc. in December 2016), SonoCiné, Inc., Fujifilm Holdings Corporation, and Aurora
Imaging Technology, Inc.
Key Findings of the Research Study:

Ionizing breast imaging technologies segment held nearly two-third share of the overall market in
2016 owing to their capability of detecting breast cancer at an early stage.